Berlin\/ Basel (Switz\u00ader\u00adland) \u2014 A Gleiss Lutz team has advi\u00adsed the global phar\u00admaceu\u00adti\u00adcal and diagno\u00adstics group Roche on the acqui\u00adsi\u00adtion of all shares in the Berlin-based TIB Molbiol Group, an expert in mole\u00adcu\u00adlar diagno\u00adstics. The closing of the tran\u00adsac\u00adtion is subject to custo\u00admary closing condi\u00adti\u00adons and is expec\u00adted to occur in the fourth quar\u00adter of 2021. The acqui\u00adsi\u00adtion expands Roche\u2019s broad port\u00adfo\u00adlio in mole\u00adcu\u00adlar diagno\u00adstics solu\u00adti\u00adons with a wide range of assays for infec\u00adtious dise\u00ada\u00adses, such as SARS-CoV2 variants.<\/p>\n
Roche is a global company in the rese\u00adarch and deve\u00adlo\u00adp\u00adment of medi\u00adci\u00adnes and diagno\u00adstics. In addi\u00adtion, Roche is the worl\u00add\u2019s largest biotech company with drugs for onco\u00adlogy, immu\u00adno\u00adlogy, infec\u00adtious dise\u00ada\u00adses, ophthal\u00admo\u00adlogy and dise\u00ada\u00adses of the
\nCentral nervous system.<\/p>\n
Foun\u00added in 1896 and head\u00adquar\u00adte\u00adred in Basel, Switz\u00ader\u00adland, the Roche Group opera\u00adtes in more than 100 count\u00adries and employed more than 100,000 people world\u00adwide in 2020. In 2020, Roche inves\u00adted CHF 12.2 billion in rese\u00adarch and deve\u00adlo\u00adp\u00adment and gene\u00adra\u00adted sales of CHF 58.3 billion.<\/p>\n
The biotech\u00adno\u00adlogy company TIB Molbiol was foun\u00added in 1990 and has been supp\u00adly\u00ading the inter\u00adna\u00adtio\u00adnal market with diagno\u00adstic and rese\u00adarch reagents ever since. As a manu\u00adfac\u00adtu\u00adrer of custom oligo\u00adnu\u00adcleo\u00adti\u00addes, the company is a part\u00adner in the deve\u00adlo\u00adp\u00adment of mole\u00adcu\u00adlar diagno\u00adstics and has a broad port\u00adfo\u00adlio of diagno\u00adstic assays. The Berlin-based company has sites in the USA, Colom\u00adbia, Italy, Spain and Australia.<\/p>\n
Dr. Ruben Perren and Dr. Felix Kobel from Roche\u2019s legal depart\u00adment were respon\u00adsi\u00adble for the transaction.<\/p>\n
The follo\u00adwing Gleiss Lutz team acted for Roche in the transaction:<\/strong> Gleiss Lutz has advi\u00adsed Roche on seve\u00adral tran\u00adsac\u00adtions in the past, inclu\u00adding the sale of Roche Diagno\u00adstics IT Solu\u00adti\u00adons GmbH to Nexus AG.<\/p>\n","protected":false},"excerpt":{"rendered":" Berlin\/ Basel (Switz\u00ader\u00adland) \u2014 A Gleiss Lutz team has advi\u00adsed the global phar\u00admaceu\u00adti\u00adcal and diagno\u00adstics group Roche on the acqui\u00adsi\u00adtion of all shares in the Berlin-based TIB Molbiol Group, an expert in mole\u00adcu\u00adlar diagno\u00adstics. The closing of the tran\u00adsac\u00adtion is subject to custo\u00admary closing condi\u00adti\u00adons and is expec\u00adted to occur in the fourth quar\u00adter of [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":38046,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1371,1372],"tags":[],"class_list":["post-40270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-deals-en","category-consultant"],"yoast_head":"\n
\nDr. Alex\u00adan\u00adder Schwarz (Part\u00adner, D\u00fcssel\u00addorf), Dr. Martin Viciano Gofferje (Part\u00adner, Berlin, both Lead), Dr. Fabian Mumme (D\u00fcssel\u00addorf), Dr. Chris\u00adtoph Meiss\u00adner (Berlin), Fried\u00adrich Baum\u00adg\u00e4r\u00adtel, Kai Zimutta (both D\u00fcssel\u00addorf, all M&A), Dr. Alex\u00adan\u00adder Molle (Part\u00adner), Jan Hinrichs, Dr. Felix M\u00fcller (all IP\/IT), Dr. Enno Burk (Coun\u00adsel, Health\u00adcare, all Berlin), Dr. Johann Wagner (Part\u00adner, Tax, Hamburg), Dr. Jacob von Andreae (Part\u00adner), Aylin Hoffs, Matthias Hahn, Lenn\u00adart F\u00f6rs\u00adter (all Public Commer\u00adcial Law, D\u00fcssel\u00addorf), Dr. Ingo Brin\u00adker (Part\u00adner), Dr. Iris Bene\u00addikt-Bucken\u00adleib (Coun\u00adsel, both Anti\u00adtrust, Munich), Dr. Stefan Linge\u00admann (Part\u00adner), Jose\u00adfine Chakrab\u00adarti (both Berlin), Dr. Simona Kreis (Hamburg, all Labor Law), Konrad Discher (Coun\u00adsel, Real Estate, Frankfurt).<\/p>\n